venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 8
- +1 vs. Q2 2023
- Portfolio value
- $352.7M
- +$76.3M (+27.6%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RYZBRayzeBio, Inc. | COM | 5,158,162 | $114.5M | 32.5% | +5,158,162 | New | History |
| PHVSPharvaris N.V. | COM | 4,264,672 | $89.0M | 25.2% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $46.6M | 13.2% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 3,852,470 | $39.2M | 11.1% | −4,760−0.1% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $33.9M | 9.6% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 758,800 | $26.4M | 7.5% | +334,768+78.9% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,914,255 | $1.93M | 0.5% | 00.0% | Unchanged | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $1.19M | 0.3% | 00.0% | Unchanged | History |